Is disease extent at secondary cytoreductive surgery predictive of progression-free and overall survival in advanced stage ovarian cancer : An NRG Oncology/Gynecologic Oncology Group study?
Although as previously reported SCS did not change PFS or OS, for those who underwent the procedure, their operative and pathologic findings were predictive of PFS and OS. Surgical/pathological residual disease is a biomarker of response to chemotherapy and predictive of PFS and OS.
Calcium entry via ORAI1 and CRAC channels are important for GBM proliferation and survival.